| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Vertex Pharmaceuticals Incorporated (VRTX) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 45 sells. VRTX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 133.5K | $60.29M | - | |
| COO | 63.4K | $28.62M | - | |
| VP | 51.1K | $23.07M | - | |
| VP | 42.3K | $19.10M | - | |
| Other | 24.0K | $10.85M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 22, 2023 | Arbuckle Stuart A | EVP, COO | Sell | 2,401 | $294.33 | $706,678.70 | -0.7% | +13.3% | +45.0% | |
| Feb 21, 2023 | Altshuler David48 | EVP, Global Research And CSO | Sell | 4,002 | $293.77 | $1,175,676.13 | -2.3% | +16.2% | +43.5% | |
| Feb 21, 2023 | Tatsis Ourania48 | EVP, Chief Reg. &Quality Off. | Sell | 480 | $293.75 | $141,001.58 | -0.2% | +16.2% | +43.5% | |
| Feb 21, 2023 | Arbuckle Stuart A | EVP, COO | Sell | 2,402 | $293.75 | $705,595.74 | -0.9% | +16.2% | +43.5% | |
| Feb 14, 2023 | Arbuckle Stuart A | EVP, COO | Sell | 6,398 | $298.68 | $1,910,961.70 | -1.3% | +16.1% | +39.2% | |
| Feb 14, 2023 | Tatsis Ourania48 | EVP, Chief Reg. &Quality Off. | Sell | 320 | $298.52 | $95,526.51 | - | +16.1% | +39.2% | |
| Feb 14, 2023 | Altshuler David48 | EVP, Global Research And CSO | Sell | 6,398 | $298.70 | $1,911,107.89 | -2.1% | +16.1% | +39.2% | |
| Feb 14, 2023 | Sanna Bastiano | EVP, Cell &Genetic Therapies | Sell | 2,181 | $300.39 | $655,161.27 | -1.8% | +16.1% | +39.2% | |
| Feb 13, 2023 | Arbuckle Stuart A | EVP, COO | Sell | 4,887 | $298.92 | $1,460,815.65 | -1.4% | +16.5% | +39.1% | |
| Feb 13, 2023 | Tatsis Ourania48 | EVP, Chief Reg. &Quality Off. | Sell | 275 | $298.99 | $82,222.87 | - | +16.5% | +39.1% |